Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2023 Jul;73(7):317-322.
doi: 10.1111/pin.13346. Epub 2023 Jun 14.

Adenocarcinoma arising in branchioma with a KRAS and TP53 mutation

Natsuki Taniguchi  1 , Akira Satou  1 , Takanori Ito  1 , Masato Nakaguro  2 , Toyonori Tsuzuki  1
Affiliations
Case Reports

Adenocarcinoma arising in branchioma with a KRAS and TP53 mutation

Natsuki Taniguchi et al. Pathol Int. 2023 Jul.

Abstract

Branchioma is a rare benign neoplasm occurring in the lower neck. Occurrence of malignant neoplasms arising in branchioma is extremely rare. Here, we report a case of adenocarcinoma arising in branchioma. A 62-year-old man had a right supraclavicular mass measuring 7.5 cm in diameter. The tumor contained an adenocarcinoma component encapsulated in a benign branchioma component. The adenocarcinoma component consisted of high- and low-grade components, with the former accounting for 80% of the adenocarcinoma. The high-grade component was immunohistochemically characterized by diffuse strong p53 expression, while the low-grade component and branchioma component were negative for p53. Targeted sequencing analysis for the branchioma and adenocarcinoma components revealed that the adenocarcinoma component harbored pathogenic mutations in KRAS and TP53. No definitive oncogenic drivers were detected in the branchioma component. Based on these immunohistochemical and molecular findings, we suggest that the KRAS mutation contributed to the pathogenesis of the adenocarcinoma, and the TP53 mutation played a key role in the transition from low-grade to high-grade adenocarcinoma.

Keywords: KRAS; TP53; adenocarcinoma; branchioma; ectopic hamartomatous thymoma.

PubMed Disclaimer

References

REFERENCES

    1. Smith PS, McClure J. Unusual subcutaneous mixed tumour exhibiting adipose, fibroblastic, and epithelial components. J Clin Pathol. 1982;35:1074-7.
    1. Rosai J, Limas C, Husband EM. Ectopic hamartomatous thymoma. A distinctive benign lesion of lower neck. Am J Surg Pathol. 1984;8:501-14.
    1. Sato K, Thompson LDR, Miyai K, Kono T, Tsuda H. Ectopic hamartomatous thymoma: a review of the literature with report of new cases and proposal of a new name: biphenotypic branchioma. Head Neck Pathol. 2018;12:202-09.
    1. Weissferdt A, Kalhor N, Petersson F, Moran CA. Ectopic hamartomatous thymoma-new insights into a challenging entity: a clinicopathologic and immunohistochemical study of 9 cases. Am J Surg Pathol. 2016;40:1571-76.
    1. Thompson LDR, Gagan J, Washington A, Miller RT, Bishop JA. Biphenotypic branchioma: a better name than ectopic hamartomatous thymoma for a neoplasm with HRAS mutation. Head Neck Pathol. 2020;14:884-88.

Publication types

Substances

LinkOut - more resources